FIGO STAGE IV OVARIAN CANCER 2014
Clinical trials for FIGO STAGE IV OVARIAN CANCER 2014 explained in plain language.
Never miss a new study
Get alerted when new FIGO STAGE IV OVARIAN CANCER 2014 trials appear
Sign up with your email to follow new studies for FIGO STAGE IV OVARIAN CANCER 2014, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shorter maintenance may be just as effective for ovarian cancer patients
Disease control Recruiting nowThis study tests whether taking the drug olaparib for one year works as well as taking it for two years to keep ovarian cancer from coming back. Participants have a specific genetic type (BRCA mutation or HRD) and have already responded to initial chemotherapy. Some will also rec…
Matched conditions: FIGO STAGE IV OVARIAN CANCER 2014
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New vaccine aims to keep ovarian cancer at bay
Disease control Recruiting nowThis study tests a vaccine made from a patient's own white blood cells, designed to train the immune system to attack ovarian cancer cells. It is for people with advanced stage III or IV ovarian, fallopian tube, or primary peritoneal cancer. The goal is to see if the vaccine can …
Matched conditions: FIGO STAGE IV OVARIAN CANCER 2014
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:41 UTC